Clinical and Immunological Evaluation of the Effectiveness of Non-Penetrating Deep Sclerectomy in the Early Postoperative Period

Today the mechanisms of pathological scarring and inconsistency of the intraocular fluid outflow pathways after nonpenetrating deep sclerectomy (NPDS), reducing its effectiveness, have not yet been determined. There is no systematic information about the regulatory role of cytokine TGF-β and MMP-9 in the mechanisms of formation of the newly created intraocular fluid outflow pathways.

Aim: to assess changes in the clinical and immunological status of patients with open-angle glaucoma after NPDS in the early postoperative period.

Methods. A prospective examination of 26 patients with open-angle glaucoma before and in 1 month after NPDS with determination of concentration of TGF-β and MMP-9 in tear humor. One month after NPDS, all patients were divided into two groups depending on the effect of the operation achieved according to the developed criteria.

Results. Before the operation, tears TGF-β values in group 1 exceeded baseline values of group 2 by 1.4 times, the initial content of MMP-9 in tears in both groups was comparable. After the operation, in group 1, a moderate increase in the concentration of tears TGF-β by 1.3 times and a significant increase in the concentration of tears MMP-9 in 4.6 times compared with baseline values were revealed. In patients of group 2, after NPDS, there was a significant increase in the concentration of tears TGF-β, on average, 2.4 times relative to preoperative values, the content of MMP-9 did not significantly change.

Conclusion. 1 month after NPDS, an imbalance in the concentration of TGF-β and MMP-9 in tears was detected in patients of the two groups that have fundamental clinical differences in the hypotensive effect and the formation of postoperative intraocular fluid outflow pathways.

1. Kurysheva NI, Marnykh SA, Borzinok SA. The use of physiological regulators of reparation in glaucoma surgery (clinical and immunological study). The Russian Annals of Ophthalmology. 2005; (6): 21-25. (In Russ.)

2. Volkova NV, Shchuko AG, Malyshev VV. Retrospective analysis of risk factors for development of scarring intraocular fluid outflow pathways after fistulizing antiglaucomatous operations. Glaukoma. 2010; (3): 35-40. (In Russ.)

3. Volkova NV, Shchuko AG, Malysheva YuV, Iureva TN. Inadequate reparative regeneration in fistulizing glaucoma surgery. Fyodorov Journal of Ophthalmic Surgery. 2014; (3): 60-66. (In Russ.)

4. Chang L, Cheng Q, Lee DA. Basic science and clinical aspects of wound healing in glaucoma filtering surgery. J Ocul Pharmacol Ther. 1998; 14(1): 75-95. doi: 10.1089/jop.1998.14.75

5. Chang L, Crowston JG, Cordeiro MF, Akbar AN, Khaw PT. The role of the immune system in conjunctival wound healing after glaucoma surgery. Surv Ophthtalmol. 2000; 45(1): 49-68. doi: 10.1016/S0039-6257(00)00135-1

6. Avdeev RV, Aleksandrov AS, Basinsky AS, Blyum EA, Brezhnev AYu, Volkov EN, et al. Clinical multicenter study of the efficacy of sinus trabeculectomy.Glaukoma. 2013; (2): 53-60. (In Russ.)

7. Yegorov EA, Kuroedov AV. Separate clinical and epidemiological characteristics of glaucoma in the CIS countries and Georgia. Results of a multicenter open retrospective study. Russian Journal of Clinical Ophtalmology. 2012; (1): 19-22. (In Russ.)

8. Titov VN. The role of macrophages in the formation of inflammation, the action of interleukin-1, interleukin-6 and the activity of the hypothalamic-pituitary system (Literature review). Russian Clinical Laboratory Diagnostics. 2003; (12): 3-10. (In Russ.)

9. Reynolds AC, Skuta GL. Clinical perspectives on glaucoma-filtering surgery. Antiproliferative agents. Ophthalmol Clin North America. 2000; 13(3): 501-515. doi: 10.1016/S08961549(05)70210-8

10. Picht G, Welge-Luessen U, Grehn F, Lutjen-Drecoll E. Transforming growth factor beta 2 levels in the aqueous humor in different types of glaucoma and the relation to filtering bleb development. Graefes Arch Clin Exp Ophthalmol. 2001; 239(3): 199-207.

11. Zenkel M, Lewczuk P, Junemann A, Kruse FE, Naumann GO, Schlotzer-Schrechardt U. Proinflammatory cytokines are involved in the initiation of the abnormal matrix process in pseudoexfoliation syndrome glaucoma. Am J Pathology. 2010; 176(6): 2868-2879. doi: 10.2353/ajpath.2010.090914

12. Lama PJ, Fecthner RD. Antifibrotics and wound healing in glaucoma surgery. Surv Ophthalmol. 2003; 48(3): 314-346. doi: 10.1016/S0039-6257(03)00038-9

13. Fedorov SN, Kozlov VI, Timoshkina NT. Non-penetrating deep sclerectomy for open-angle glaucoma. Fyodorov Journal of Ophthalmic Surgery. 1989; (3-4): 52-55. (In Russ.)

14. Goldsmith JA, Ahmed IK, Crandall AS. Non-penetrating glaucoma surgery. Ophthalmol Clin North Am. 2005; 18(3): 443-460. doi: 10.1016/j.ohc.2005.05.008

15. Volkova NV, Iureva TN, Shchuko AG, Malyshev VV. Classification of intraocular fluid outflow pathways of intraocular fluid after fistulizing antiglaucomatous operations. Glaukoma. 2008; (3): 16-20. (In Russ.)

16. Chekmareva LT, Iureva TN, Volkova NV. Topical localization of blocks in the outflow paths using the ultrasonic method. Acta biomedica scientifica. 2000; (4): 20-22. (In Russ.)

17. Takhchidi KhP, Egorova EV, Uzunyan DG. Ultrasound biomicroscopy in the diagnosis of pathology of the anterior segment of the eye. Moscow: Eye microsurgery; 2007. (In Russ.)

18. Takai Y, Tanito M, Ohira A. Multiplex cytokine analysis of aqueous humor in eyes with primary open-angle glaucoma, exfoliation glaucoma and cataract.Invest Ophthalmol Vis Sci. 2012; 53(1): 241-247. doi: 10.1167/iovs.11-8434

19. Kasparova EA. On the use of cytokines and their complexes in ophthalmology. The Russian Annals of Ophthalmology. 2002; (4): 47-49. (In Russ.)